Skip to main content
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. — Investor Relations & Filings

Ticker · FLGT ISIN · US3596641098 LEI · 549300CL6P01M68QJ404 US Human health and social work activities
Filings indexed 618 across all filing types
Latest filing 2026-05-14 Registration Form
Country US United States of America
Listing US FLGT

About Fulgent Genetics, Inc.

https://www.fulgentgenetics.com/

Fulgent Genetics, Inc. is a technology company providing comprehensive, flexible, and rapid genetic testing solutions. Leveraging a proprietary technology platform with next-generation sequencing (NGS) and AI-powered diagnostics, the company offers a broad menu of clinical diagnostic tests. Its services are designed to improve patient outcomes and support precision medicine in areas such as oncology, rare diseases, infectious diseases, and reproductive health. Fulgent focuses on delivering accurate and affordable genomic testing to physicians and healthcare providers to aid in the diagnosis, treatment, and management of complex diseases.

Recent filings

Filing Released Lang Actions
S-8
Registration Form
2026-05-14 English
DEF 14A - Fulgent Genetics, Inc. (0001674930) (Filer)
Proxy Solicitation & Information Statement
2026-03-31 English
4 - FULGENT GENETICS, INC. (0001674930) (Filer)
Director's Dealing
2026-03-03 English
4 - FULGENT GENETICS, INC. (0001674930) (Filer)
Director's Dealing
2026-03-03 English
4 - FULGENT GENETICS, INC. (0001674930) (Filer)
Director's Dealing
2026-03-03 English
4 - FULGENT GENETICS, INC. (0001674930) (Filer)
Director's Dealing
2026-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.